RxStrategies

October 2017 – 340B Insider

Welcome to the October edition of RxStrategies’ 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view.    340B INDUSTRY NEWS UPDATE: HOUSE ENERGY & COMMERCE OVERSIGHT SUBCOMMITTEE HEARING On October 11, the House Energy & Commerce (E&C) oversight subcommittee held a second hearing on the 340B program, focusing on how Covered…

Read More...

NOVEMBER 2016 – 340B INSIDER

Welcome to the November edition of RxStrategies 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view. AFFORDABLE CARE ACT – WHAT IS ON THE HORIZON RxStrategies works closely with a number of industry thought leaders to keep a pulse on issues potentially impacting the 340B Drug Pricing Program. With…

Read More...

RxStrategies Clinical Insights — November 2015, Issue 2

Welcome to the second November edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.     New Drug Approval Ninlaro® (ixazomib) November 20, 2015 – The U.S. Food and Drug Administration approved ixazomib (Ninlaro®, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical…

Read More...

RxStrategies Celebrates 50 Years of Excellence for ASHP

Rhodie, Skip, David and Fenton, from the RxStrategies team, will be traveling to New Orleans from Dec. 6 – 10 for The 50th ASHP Midyear Clinical Meeting and Exhibition.   Stop by Booth 352 during ‘the largest gathering of pharmacists and the longest-running clinical meeting in the world!

Read More...

RxStrategies, Inc. Names Skip Devanny Chief Revenue Officer

BOCA RATON, Fla., October 28, 2015—RxStrategies, Inc. (www.rxstrategies.com) is pleased to announce the appointment of Skip Devanny to the position of Chief Revenue Officer. In this new role, Skip joins the RxStrategies’ senior leadership team and has responsibility for sales and marketing including the delivery of customized 340B pharmacy administration and split billing solutions to the growing 340B marketplace. “I…

Read More...

RxStrategies Helps Place Health at the Center of Communities

From Aug. 23-25, RxStrategies will present during the NACHC Community Health Institute (CHI) & Expo in Orlando, Florida. Schedule a meeting or stop by booth #212 to connect with our team. At an afternoon education session on Monday, Aug. 24, the RxStrategies team will discuss the 340B Drug Pricing Program and the latest updates on the federal…

Read More...

August 340B Insider

Welcome to the August edition of RxStrategies 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view.   340B RECERTIFICATION REMINDER   Recertification Deadline September 9    340B Health sent a reminder to Covered Entities (CEs) regarding the Sept. 9 deadline to recertify information in the 340B program database. It is vital to…

Read More...

RxStrategies to Connect with Health Care Leaders at the MPHCA 28th Annual Conference

From June 10 to 12, our team will be in Mississippi for the 28th Annual Conference by the Mississippi Primary Health Care Association (MPHCA). MPHCA expects to welcome almost 300 attendees, speakers, vendors and guests to the conference. Stop by booth #10 to discuss with 340B experts how to ensure your program is compliant and…

Read More...